The Annals of Surgical Oncology (ASO) and SSO have partnered to release a new podcast, Speaking of SurgOnc™, hosted by ASO Deputy Editor, Frederick L. (Rick) Greene, MD. Through interviews with SSO members who are experts in the field, monthly podcast episodes will expand upon clinical concepts from articles published in the Annals of Surgical Oncology.
Episode One: “The 8th Edition of TNM: Implications for the Surgical Oncologist.” Dr. Rick Greene and Dr. David R. Byrd discuss the 8th edition of the TNM staging system, which through its advances supports the concept of a team approach to cancer staging by clinical oncologists, including cancer registrars, pathologists, and radiologists.
Episode Two: “Melanoma Staging: American Joint Committee on Cancer 8th Edition and Beyond. ” Dr. Rick Greene discusses the 8th edition of the TNM staging system for melanoma and its use for communication between physicians and their patients, as well as its impact on decision-making and prognostic assessment with Dr. Jeffrey E. Gershenwald, who is co-author of the ASO TNM staging editorial, “Melanoma Staging: American Joint Committee on Cancer (AJCC) 8th Edition and Beyond .”
Episode Three: “The 8th Edition of the AJCC Cancer Staging Manual: Breast Cancer.” Dr. Rick Greene and Dr. Stephen Edge discuss the TNM staging system and its relevance to breast cancer management. Dr. Edge was Editor-in-Chief of the 7th Edition of the AJCC Cancer Staging Manual published in 2009 and co-author with Drs. Armando E. Giuliano and Gabriel N. Hortobagyi of the ASO editorial, “Eighth Edition of the AJCC Cancer Staging Manual: Breast Cancer.”
Episode 4: “The 8th Edition of the AJCC Cancer Staging Manual: Pancreas and Hepatobiliary Cancers.” Dr. Rick Greene and Dr. Tim Pawlik discuss the 8th edition of the TNM staging system for pancreas and hepatobiliary cancers, which affirms that the anatomic extent of disease remains the strongest predictor of outcome in hepatobiliary cancers.
Additional episodes are available and include: “Impact of Chemoradiation-to-Surgery interval on pathological Complete Response and Short- and Long-term Overall Survival in Esophageal Cancer Patients” with Basem Azab, MD and Modified Frailty Index predicts Morbidity and Mortality After Pancreaticoduodenectomy” with Clancy J. Clark, MD.